Lucid strengthens their medical writing team with new hires
Sep 26, 2018
Leading Edge, part of the Lucid Group family of companies, are set to create more magical programmes for their clients and patients by strengthening their talented medical writing team with three new hires.
Kerrie O’Rourke joins Leading Edge as a Scientific Director and will be based in Macclesfield.“It’s great to work with such a fantastic and talented team. Everyone here works hard to ensure we deliver truly market-leading solutions to our clients. I’m looking forward to seeing the Macclesfield office grow as we continue to expand our presence in the North West” comments Kerrie, who has over 16 years’ experience in health care communications.
John Wiltshire also joins as an Executive Scientific Director and will be based in High Wycombe. “I’m excited to be joining Leading Edge at such an exciting time for the company, working with a strategic team that not only talks about improving patients’ lives but delivers measurable behaviour change outcomes”, commented John.
Claudia Wiedemann joins the team as a Principle Medical Writer. “I am excited to be part of such an innovative and pioneering healthcare communications group. The passionate, visionary and human-centric approach mixed with a resilient team spirit is the magical recipe to achieving change and ultimately improve patients’ lives” she comments. Claudia will be based in our Farringdon office and has 7 years’ experience in medical communications.
Three new hires across three offices really speaks volumes about Lucid’s commitment to finding the best talent, but also their commitment agile working. You can read more about what agile working means to Lucid in an article by Angela Young (HR Director) here.
- Lucid Group announces the appointment of new CFO
- Lucid Group Launch a Pioneering Leadership Programme for its Business Leaders
- Leading Edge, a Lucid Group company, strengthens its senior client services team
- From Cowgirl to Medical Writer – How did that happen?
- Measures for measures – Why pharma’s marketing metrics must close the loop